Literature DB >> 22262592

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.

Jeremy A Rassen1, Sebastian Schneeweiss.   

Abstract

Distributed medical product safety monitoring systems such as the Sentinel System, to be developed as a part of Food and Drug Administration's Sentinel Initiative, will require automation of large parts of the safety evaluation process to achieve the necessary speed and scale at reasonable cost without sacrificing validity. Although certain functions will require investigator intervention, confounding control is one area that can largely be automated. The high-dimensional propensity score (hd-PS) algorithm is one option for automated confounding control in longitudinal healthcare databases. In this article, we discuss the use of hd-PS for automating confounding control in sequential database cohort studies, as applied to safety monitoring systems. In particular, we discuss the robustness of the covariate selection process, the potential for over- or under-selection of variables including the possibilities of M-bias and Z-bias, the computation requirements, the practical considerations in a federated database network, and the cases where automated confounding adjustment may not function optimally. We also outline recent improvements to the algorithm and show how the algorithm has performed in several published studies. We conclude that despite certain limitations, hd-PS offers substantial advantages over non-automated alternatives in active product safety monitoring systems.
Copyright © 2012 John Wiley & Sons, Ltd.

Mesh:

Year:  2012        PMID: 22262592     DOI: 10.1002/pds.2328

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  37 in total

1.  Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system.

Authors:  Patrick B Ryan; Martijn J Schuemie; Susan Gruber; Ivan Zorych; David Madigan
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

2.  Improving propensity score estimators' robustness to model misspecification using super learner.

Authors:  Romain Pirracchio; Maya L Petersen; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-12-16       Impact factor: 4.897

Review 3.  Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.

Authors:  Elisabetta Patorno; Elizabeth M Garry; Amanda R Patrick; Sebastian Schneeweiss; Victoria G Gillet; Olesya Zorina; Dorothee B Bartels; John D Seeger
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

4.  Effect Estimation in Point-Exposure Studies with Binary Outcomes and High-Dimensional Covariate Data - A Comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting.

Authors:  Menglan Pang; Tibor Schuster; Kristian B Filion; Mireille E Schnitzer; Maria Eberg; Robert W Platt
Journal:  Int J Biostat       Date:  2016-11-01       Impact factor: 0.968

5.  Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules.

Authors:  Joshua J Gagne; Jeremy A Rassen; Alexander M Walker; Robert J Glynn; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

Review 6.  Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.

Authors:  Elisabetta Patorno; Amanda R Patrick; Elizabeth M Garry; Sebastian Schneeweiss; Victoria G Gillet; Dorothee B Bartels; Elvira Masso-Gonzalez; John D Seeger
Journal:  Diabetologia       Date:  2014-09-12       Impact factor: 10.122

7.  Propensity score methods and unobserved covariate imbalance: comments on "squeezing the balloon".

Authors:  M Sanni Ali; Rolf H H Groenwold; Olaf H Klungel
Journal:  Health Serv Res       Date:  2014-01-24       Impact factor: 3.402

8.  Commentary: Balancing automated procedures for confounding control with background knowledge.

Authors:  Richard Wyss; Til Stürmer
Journal:  Epidemiology       Date:  2014-03       Impact factor: 4.822

9.  An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.

Authors:  Xiaofeng Zhou; Sundaresan Murugesan; Harshvinder Bhullar; Qing Liu; Bing Cai; Chuck Wentworth; Andrew Bate
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606

10.  Risk of pneumonia in new users of cholinesterase inhibitors for dementia.

Authors:  Edward Chia-Cheng Lai; Monera B Wong; Isao Iwata; Yinghong Zhang; Cheng-Yang Hsieh; Yea-Huei Kao Yang; Soko Setoguchi
Journal:  J Am Geriatr Soc       Date:  2015-04-27       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.